VANGUARD GROUP INC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 26 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$168,000
+10.5%
443,923
+136.6%
0.00%
Q2 2019$152,000
-20.4%
187,588
+13.4%
0.00%
Q1 2019$191,000
+50.4%
165,492
+1.3%
0.00%
Q4 2018$127,000
-83.9%
163,292
-57.3%
0.00%
Q3 2018$787,000
-79.7%
382,105
+0.3%
0.00%
Q2 2018$3,883,000
+58.1%
381,091
+1.0%
0.00%
Q1 2018$2,456,000
+89.1%
377,331
+130.9%
0.00%
Q4 2017$1,299,000
-11.3%
163,434
+5.3%
0.00%
Q3 2017$1,464,000
+266.9%
155,177
+402.2%
0.00%
Q2 2017$399,000
+193.4%
30,898
+137.6%
0.00%
Q1 2017$136,00013,0060.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders